Table 1.
Demographic and clinical characteristics of patients with NCFB
| Patients | n=74 |
|---|---|
| Age (years) | 47±17 |
| Sex F/M (%) | 44/30(59/41) |
| BMI (kg/m2) | 26±6 |
| Smoking history | |
| Non-smokers | 56 |
| Active smokers | 6 |
| Ex-smokers | 12 |
| History of tuberculosis | 12 |
| mMRC | 1 (0–4) |
| Colonization of microorganism | |
| Pseudomonas aeruginosa | 20 |
| Acromobacter | 1 |
| Haemophilus influenzae | 15 |
| Streptococcus pneumoniae | 1 |
| Klebsiella pneumoniae | 1 |
| Moraxella catarhalis | 1 |
| Methicillin-sensitive Staphylococcus aureus | 1 |
| H. influenza+streptococcus | 1 |
| Number of exacerbations within the past year | 3.11 (0–10) |
| Number of hospitalizations within the past year | 1.5 (0–4) |
| Disease duration (years) | 5 (1–40) |
| Charlson comorbidity index | 1 (1–6) |
| Lung function test results | |
| FEV1% | 70.2±29.5 |
| FEV1 (L) | 2.02±0.96 |
| FVC% | 78.4±24.9 |
| FVC (L) | 2.71±1.11 |
| FEV1/FVC % | 70.4±14.5 |
| MMEF % | 44±36 |
| MMEF (L) | 1.63±1.37 |
| DLCO % | 86±25 |
| DLCO L/min/mmHg | 7.47±2.65 |
NCFB: non-cystic fibrosis bronchiectasis; F/M: female/male; BMI: body mass index; mMRC: modified medical research council dyspnea score; FEV1: forced expiratory volume in the first second; FVC: forced vital capacity; MMEF: maximal mid-expiratory flow; DLCO: diffusing capacity of lung for carbon monoxide
Frequencies expressed as n (%), parametric data as mean±standard deviation, and non-parametric data as median (min–max) values.